Literature DB >> 17054239

Acupuncture for treatment of irritable bowel syndrome.

B Lim1, E Manheimer, L Lao, E Ziea, J Wisniewski, J Liu, B Berman.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS), a disorder of altered bowel habits associated with abdominal pain or discomfort. The pain, discomfort, and impairment from IBS often lead to healthcare medical consultation (Talley 1997) and workplace absenteeism, and associated economic costs (Leong 2003). A recent randomized controlled trial shows variable results but no clear evidence in support of acupuncture as an effective treatment for IBS (Fireman 2001).
OBJECTIVES: The objective of this systematic review is to determine whether acupuncture is more effective than no treatment, more effective than 'sham' (placebo) acupuncture, and as effective as other interventions used to treat irritable bowel syndrome. Adverse events associated with acupuncture were also assessed. SEARCH STRATEGY: The following electronic bibliographic databases were searched irrespective of language, date of publication, and publication status: MEDLINE, the Cochrane Central Register of Controlled Trials (CENTRAL) on The Cochrane Library, EMBASE, the Chinese Biomedical Database, the Cumulative Index to Nursing and Allied Health (CINAHL), and the Allied and Complementary Medicine Database (AMED). References in relevant reviews and RCTs were screened by hand. The last date for searching for studies was 7 February 2006. SELECTION CRITERIA: Published reports of randomized controlled trials (RCTs) and quasi-randomised trials of acupuncture therapy for IBS. DATA COLLECTION AND ANALYSIS: All eligible records identified were dually evaluated for eligibility and dually abstracted. Methodological quality was assessed using the Jadad scale and the Linde Internal Validity Scale. Data from individual trials were combined for meta-analysis when the interventions were sufficiently similar. Heterogeneity was assessed using the I squared statistic. MAIN
RESULTS: Six trials were included. The proportion of responders, as assessed by either the global symptom score or the patient-determined treatment success rate, did not show a significant difference between the acupuncture and the sham acupuncture group with a pooled relative risk of 1.28 (95% CI 0.83 to 1.98; n=109). Acupuncture treatment was also not significantly more effective than sham acupuncture for overall general well-being, individual symptoms (e.g., abdominal pain, defecation difficulties, diarrhea, and bloating), the number of improved patients assessed by blinded clinician, or the EuroQol score. For two of the studies without a sham control, acupuncture was more effective than control treatment for the improvement of symptoms: acupuncture versus herbal medication with a RR of 1.14(95% CI 1.00 to 1.31; n=132); acupuncture plus psychotherapy versus psychotherapy alone with a RR of 1.20 (95% CI 1.03 to 1.39; n=100). When the effect of ear acupuncture treatment was compared to an unclearly specified combination of one or more of the drugs diazepam, perphenazine or domperidone, the difference was not statistically significant with a RR of 1.49(95% CI 0.94 to 2.34; n=48). AUTHORS'
CONCLUSIONS: Most of the trials included in this review were of poor quality and were heterogeneous in terms of interventions, controls, and outcomes measured. With the exception of one outcome in common between two trials, data were not combined. Therefore, it is still inconclusive whether acupuncture is more effective than sham acupuncture or other interventions for treating IBS.

Entities:  

Mesh:

Year:  2006        PMID: 17054239     DOI: 10.1002/14651858.CD005111.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  44 in total

1.  Irritable bowel syndrome--the main recommendations.

Authors:  Viola Andresen; Jutta Keller; Christian Pehl; Michael Schemann; Jan Preiss; Peter Layer
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

Review 2.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

Review 3.  Acupuncture for treatment of irritable bowel syndrome.

Authors:  Eric Manheimer; Ke Cheng; L Susan Wieland; Li Shih Min; Xueyong Shen; Brian M Berman; Lixing Lao
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

4.  The treatment of irritable bowel syndrome.

Authors:  Brian E Lacy; Kirsten Weiser; Ryan De Lee
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

5.  Commentary: Good, but not perfect.

Authors:  Mike Clarke
Journal:  BMJ       Date:  2008-03-08

Review 6.  Evidence from the Cochrane Collaboration for Traditional Chinese Medicine therapies.

Authors:  Eric Manheimer; Susan Wieland; Elizabeth Kimbrough; Ker Cheng; Brian M Berman
Journal:  J Altern Complement Med       Date:  2009-09       Impact factor: 2.579

7.  Comparison of electroacupuncture and moxibustion on brain-gut function in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.

Authors:  Ji-meng Zhao; Jin-hua Lu; Xiao-jun Yin; Xing-kui Chen; Yue-hua Chen; Wei-jun Tang; Xiao-ming Jin; Lu-yi Wu; Chun-hui Bao; Huan-gan Wu; Yin Shi
Journal:  Chin J Integr Med       Date:  2015-04-06       Impact factor: 1.978

8.  Effectiveness of acupuncture to treat irritable bowel syndrome: a meta-analysis.

Authors:  Guan-Qun Chao; Shuo Zhang
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 9.  New treatments for irritable bowel syndrome in women.

Authors:  Mopelola A Adeyemo; Lin Chang
Journal:  Womens Health (Lond)       Date:  2008-11

10.  Effect of electroacupuncture on visceral hyperalgesia, serotonin and fos expression in an animal model of irritable bowel syndrome.

Authors:  Justin Cy Wu; Eric Tc Ziea; Lixing Lao; Emma Fc Lam; Catherine Sm Chan; Angela Yq Liang; Sunny Lh Chu; David Tw Yew; Brian M Berman; Joseph Jy Sung
Journal:  J Neurogastroenterol Motil       Date:  2010-07-26       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.